Pfizer will provide its anti-Covid treatment to developing countries.
–
Pfizer will sell up to four million doses of its treatment against Covid-19 to Unicef, in particular for African countries, the American laboratory announced in a press release on Tuesday, without specifying the amount of the transaction.
The United Nations Children’s Fund will be responsible for distributing Paxlovid tablets in 95 countries representing approximately 53% of the world’s population.
“Low or middle-low income countries will be able to obtain treatments at cost price while middle-high income countries will pay according to the price grid defined by Pfizer”, details the press release.
Deliveries are due to begin in April.
The Paxlovid treatment is intended above all for populations at risk (very elderly, immunocompromised people, suffering from certain rare diseases, etc.). It reduces the risk of being hospitalized or dying from Covid by around 85%, according to clinical studies.
License agreements
Last week, Pfizer struck licensing deals under the auspices of the United Nations, allowing 35 companies to manufacture a generic, less expensive version of these pills.
The licenses have been awarded to 19 Indian laboratories, five Chinese, and the others are divided between Bangladesh, Brazil, the Dominican Republic, Jordan, Israel, Mexico, Pakistan, Serbia, South Korea and Vietnam .
Over three billion doses produced
Pfizer has produced more than three billion doses of the vaccine it developed in partnership with German biotech BioNTech as Comirnaty, selling for $36.8 billion in total in 2021.
Its turnover and net profit jumped in 2021, and the group plans to sell another $32 billion this year, as well as $22 billion of its anti-Covid treatment.
–
